Charles Schwab’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Charles Schwab’s Portfolio CHTP Stock Details CHTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-113,800	Closed	-$629K	–	3204
2014 Q1	$629K	Hold	113,800	–	–	﹤0.01%	2500
2013 Q4	$505K	Buy	113,800 +18,200	+19%	+$61.5K	﹤0.01%	2585
2013 Q3	$292K	Hold	95,600	–	–	﹤0.01%	2759
2013 Q2	$230K	Buy	+95,600	New	+$193K	﹤0.01%	2839

Other funds holding CHTP

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Charles Schwab's CHTP Position: Q2 2014 in Review

Charles Schwab sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 113,800 shares — an estimated $629K sold.

Charles Schwab first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $629K in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

Charles Schwab reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
Charles Schwab sold 113,800 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $629K.
Charles Schwab first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
Charles Schwab's CHELSEA THERAPEUTICS INT'L LTD position peaked at $629K in Q1 2014.
6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Charles Schwab's 13F filing for Q2 2014, filed 30 Jul 2014.